Denik Pharma
Prominent & Leading from Nagpur, we offer denik pharma fragrip, grosix ds growth hormone denik pharma, denik pharma ototropin, denik pharma insugro igf 1 lr3 and insugro ds growth hormone denik pharma.
Denik Pharma Fragrip
Request Callback
₹ 21000 / Box Get Latest Price
| Form | Injection |
| Packaging Size | 5 VIALS OF 5MG |
| Purity | 99 % |
| Packaging Type | Box |
| Brand | DENIK PHARMA |
| Country of Origin | Made in India |
| BRAND NAME | FRAG RIP |
Minimum order quantity: 1 Box
| Contents | Vial: Tyr-hGH Fragment 177-191 lyophilised powder 5mg x 5 vials Ampoule: 2ml Sterile water for injection. |
| Administration | Intramuscular or Subcutaneous injection. |
| Storage | Store at room temperature away from heat and direct sunlight pre reconstitution. Refrigerate between 2-8’C post Reconstitution. |
| Dosage | Initial: 5 mcg/kg/day empty stomach. May increase dose gradually. Max: 12 mcg/kg/day. |
| Contraindications | Acute critical illness due to heart or abdominal surgery, multiple accidental trauma or respiratory failure; active neoplasms, proliferative or pre-proliferative diabetic retinopathy; lactation; patients with closed epiphyses. Intracranial lesions. Patients with Prader-Willi syndrome who are severely obese or have a severe respiratory impairment. |
| Special Precautions | DM; may require dose reduction in insulin. Pregnancy. Discontinue treatment if there is evidence of tumor growth. Monitoring in patients with scoliosis is recommended due to a risk of progression of scoliosis. |
| Adverse Drug Reactions | Side effects noted are tiredness, feeling of lethargy, head rush or euphoria, itching. Loss of glycaemic control in diabetics. |
| Drug Interactions | High doses of corticosteroid may inhibit growth-promoting effects of HGH Fragment 177-191 |
| Disclaimer | "Images displayed on the website are for representational purposes only which may differ from the actual purchased product. The company may change or alter the packaging design without notice." |
Grosix Ds Growth Hormone DENIK PHARMA
Request Callback
₹ 13000 / Box Get Latest Price
| Type of Steroid Hormone | Androgens |
| Usage/Application | Personal |
| Form | Injection |
| Packaging Size | 5 VIALS OF 6 MG |
| Purity | 99% |
| Delivery | 10 DAYS |
| Storage Temperature | Store at room temperature away from heat and direct sunlight pre reconstitution.; Refrigerate betwee |
| Country of Origin | Made in India |
| MANUFACTURER | DENIK PHARMA |
Minimum order quantity: 1 Box
| Contents | Vial: GROSIX-DS(GHRP 6) 6mg. Ampoule: 2ml Sterile water for injection. |
| Administration | Intramuscular or Subcutaneous injection. |
| Storage | Store at room temperature away from heat and direct sunlight pre reconstitution.; Refrigerate between;2-8’C post Reconstitution. |
| Dosage | Adult: SC Growth hormone deficiency Initial: 6 mcg/kg/day. May increase dose gradually. Max: 12.5 mcg/kg/day. HIV-associated wasting or cachexia 5 mcg/kg/day at bedtime. May take on alternate days for patients at increased risk of adverse effects. Max: 5 mg/day. |
| Contraindications | Acute critical illness due to heart or abdominal surgery, multiple accidental trauma or respiratory failure; active neoplasms, proliferative or preproliferative diabetic retinopathy; lactation; patients with closed epiphyses. Intracranial lesions. Patients with Prader-Willi syndrome who are severely obese or have severe respiratory impairment. |
| Special Precautions | Monitor thyroid function; benign intracranial hypertension. DM; may require dose reduction in insulin. Pregnancy. Discontinue treatment if there is evidence of tumour growth. Monitoring in patients with scoliosis is recommended due to risk of progression of scoliosis. |
| Drug Interactions | High doses of corticosteroid may inhibit growth-promoting effects of GHRP-6. |
| Disclaimer | "Images displayed on the website are for representational purposes only which may differ from the actual purchased product. The company may change or alter the packaging design without notice." |
Denik Pharma Ototropin
Request Callback
₹ 21000 / Box Get Latest Price
| Brand | ototropin |
| Total Strength | 100 IU |
| Form | Vial |
| Packaging Size | 5 Vials/Kit |
| Hormone Type | Somatropin |
| Usage / Application | Bodybuilding |
| Country of Origin | India |
| Kit Contents | Bacteriostatic WTR |
| made by | denik pharma |
| unit size | 20 iu vial |
Minimum order quantity: 1 Box
| Contents | hGH (191aa Human Growth Hormone) lyophilised powder 20iu x 5 vials Ampoule: 2ml Sterile water for injection. |
| Administration | Intramuscular or Subcutaneous injection. |
| Storage | Store at room temperature away from heat and direct sunlight pre reconstitution. Refrigerate between 2-8’C post Reconstitution. |
| Dosage | Adult: SC Growth hormone deficiency Initial: 6 mcg/kg/day. May increase dose gradually. Max: 12.5 mcg/kg/day. HIV-associated wasting or cachexia 0.1 mg/kg/day at bedtime. May take on alternate days for patients at increased risk of adverse effects. Max: 6 mg/day. Short bowel syndrome100 mcg/kg/day for 4 wk. Max: 8 mg/day. |
| Contraindications | Acute critical illness due to heart or abdominal surgery, multiple accidental trauma or respiratory failure; active neoplasms, proliferative or preproliferative diabetic retinopathy; lactation; patients with closed epiphyses. Intracranial lesions. Patients with Prader-Willi syndrome who are severely obese or have severe respiratory impairment. |
| Special Precautions | Monitor thyroid function; benign intracranial hypertension. DM; may require dose reduction in insulin. Pregnancy. Discontinue treatment if there is evidence of tumour growth. Monitoring in patients with scoliosis is recommended due to risk of progression of scoliosis. |
| Adverse Drug Reactions | Hypothyroidism, peripheral oedema; headache; muscle and joint pain; benign intracranial hypertension. Loss of glycaemic control in diabetics. |
| Drug Interactions | High doses of corticosteroid may inhibit growth-promoting effects of somatropin. |
| Pregnancy Category (US FDA) | Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are no controlled studies in pregnant women or animal-reproduction studies have shown an adverse effect (other than a decrease in fertility) that was not confirmed in controlled studies in women in the 1sttrimester (and there is no evidence of a risk in later trimesters). |
| ATC Classification | H01AC01 – somatropin ; |
| Disclaimer | "Images displayed on the website are for representational purposes only which may differ from the actual purchased product. The company may change or alter the packaging design without notice. |
Denik PHARMA Insugro Igf 1 Lr3
Request Callback
₹ 15000 / Box Get Latest Price
| Strength | 125MCG |
| Usage/Application | Personal |
| Packaging Size | 5X1 Vials |
| Brand | INSUGRO |
| Product Type | Finished Product |
| Delivery | 10 DAYS |
| Storage Temperature | Store at room temperature away from heat and direct sunlight pre reconstitution. Refrigerate between |
| Purity | 99% |
| Country of Origin | Made in India |
| MANUFACTURER | DENIK PHARMA |
Minimum order quantity: 1 Box
| Contents | Vial: IGF1(Insulin-Like Growth Factor1) Long R3 125mcg. Ampule: 2ml Sterile water for injection. |
| Administration | Intramuscular injection. |
| Storage | Store at room temperature away from heat and direct sunlight pre reconstitution. Refrigerate between 2-8’C post Reconstitution. |
| Dosage | Initial: .5 mcg/kg/day. May increase dose gradually. Max: 5 mcg/kg/day. Maximum period for administration 45 days. |
| Contraindications | Acute critical illness due to heart or abdominal surgery, multiple accidental trauma or respiratory failure; active neoplasms, proliferative or pre-proliferative diabetic retinopathy; lactation; patients with closed epiphyses. Intracranial lesions. Patients with Prader-Willi syndrome who are severely obese or have a severe respiratory impairment. |
| Special Precautions | Monitor thyroid function; benign intracranial hypertension. DM; may require dose reduction in insulin. Pregnancy. Discontinue treatment if there is evidence of tumor growth. Monitoring in patients with scoliosis is recommended due to a risk of progression of scoliosis. |
| Adverse Drug Reactions | Side effects noted are tiredness, feeling of lethargy, head rush or euphoria, itching. |
| Drug Interactions | High doses of corticosteroid may inhibit growth-promoting effects of IGF1LR3. |
| Disclaimer | "Images displayed on the website are for representational purposes only which may differ from the actual purchased product. The company may change or alter the packaging design without notice." |
Insugro Ds Growth Hormone denik pharma
Request Callback
₹ 15000 / Box Get Latest Price
| Type of Steroid Hormone | Glucocorticoids |
| Usage/Application | Personal |
| Form | Injection |
| Packaging Size | 5 vials per box |
| Purity | 99% |
| Delivery | 12 to 15 days |
| Country of Origin | Made in India |
Minimum order quantity: 1 Box
Denik Insugro-DS is an injectable peptide manufactured by Denik Pharma that contains IGF-1 DES, a modified version of Insulin-like Growth Factor-1. It is marketed to athletes and bodybuilders for enhancing muscle growth, recovery, and fat loss. About IGF-1 DES
- What it is: Insulin-like Growth Factor-1 Des(1-3) is a peptide that is more potent and has a shorter half-life than standard IGF-1.
- Function: It is designed to act more directly on IGF-1 receptors in muscle tissue, promoting localized muscle growth and faster tissue repair.
- Medical status: Products like Insugro-DS are not approved for general medical use and are intended for research or bodybuilding purposes.
- Muscle growth: Targets specific muscle groups for hypertrophy when injected locally.
- Faster recovery: Supports muscle and tissue regeneration after workouts or injuries.
- Fat loss: Enhances lipolysis (fat breakdown).
- Improved definition: Increases the size and density of muscle fibers.
- Hypoglycemia: Can reduce blood sugar levels, causing dizziness or fatigue.
- Water retention: May cause swelling or bloating.
- Joint pain: Can cause discomfort in joints and muscles.
- Headaches: Users may experience mild to moderate headaches.
- Nausea: Gastrointestinal discomfort may occur.
- Injection site reactions: Redness, swelling, or soreness can appear at the injection site.
- Thyroid function and intracranial pressure: Monitoring of thyroid function is recommended, and it can cause benign intracranial hypertension.
Safety and regulation- Unregulated market: IGF-1 products like Insugro-DS are often sold by third-party suppliers on websites like IndiaMART or ExportersIndia, rather than through regulated pharmacies.
- Professional guidance needed: Because it is a potent substance with significant side effects, proper usage should be guided by a healthcare professional.
- Not for medical conditions: It is not for the treatment of any medical condition and carries risks, especially for individuals with underlying health issues like diabetes, thyroid conditions, or active tumors
X
Contact Us
Anshul (CEO)
A M Traders
Plot No. 368, House No. 3232, Khamla Road, Khamla, Sindi Hindi English Primary School
Nagpur - 440025, Maharashtra, India
Send Email